S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

FitLife Brands (FTLF) Competitors

$22.47
-0.13 (-0.58%)
(As of 04:12 PM ET)

FTLF vs. CDXC, MDWD, BGXX, NAII, ACB, MNMD, CGC, SYRE, BTAI, and VAXX

Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include ChromaDex (CDXC), MediWound (MDWD), Bright Green (BGXX), Natural Alternatives International (NAII), Aurora Cannabis (ACB), Mind Medicine (MindMed) (MNMD), Canopy Growth (CGC), Spyre Therapeutics (SYRE), BioXcel Therapeutics (BTAI), and Vaxxinity (VAXX). These companies are all part of the "medical" sector.

FitLife Brands vs.

FitLife Brands (NASDAQ:FTLF) and ChromaDex (NASDAQ:CDXC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, community ranking, profitability, media sentiment and institutional ownership.

15.0% of ChromaDex shares are owned by institutional investors. 61.2% of FitLife Brands shares are owned by company insiders. Comparatively, 10.6% of ChromaDex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, FitLife Brands and FitLife Brands both had 3 articles in the media. ChromaDex's average media sentiment score of 0.62 beat FitLife Brands' score of 0.49 indicating that ChromaDex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FitLife Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ChromaDex
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

FitLife Brands has higher earnings, but lower revenue than ChromaDex. ChromaDex is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FitLife Brands$28.80M3.50$4.43M$0.8825.76
ChromaDex$72.05M1.75-$16.54M-$0.09-18.66

ChromaDex has a consensus price target of $5.80, suggesting a potential upside of 245.24%. Given ChromaDex's higher possible upside, analysts plainly believe ChromaDex is more favorable than FitLife Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ChromaDex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

FitLife Brands has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, ChromaDex has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500.

ChromaDex received 530 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 63.86% of users gave ChromaDex an outperform vote while only 0.00% of users gave FitLife Brands an outperform vote.

CompanyUnderperformOutperform
FitLife BrandsOutperform Votes
No Votes
Underperform Votes
2
100.00%
ChromaDexOutperform Votes
530
63.86%
Underperform Votes
300
36.14%

FitLife Brands has a net margin of 9.58% compared to ChromaDex's net margin of -7.76%. FitLife Brands' return on equity of 24.46% beat ChromaDex's return on equity.

Company Net Margins Return on Equity Return on Assets
FitLife Brands9.58% 24.46% 14.35%
ChromaDex -7.76%-23.28%-12.07%

Summary

FitLife Brands and ChromaDex tied by winning 8 of the 16 factors compared between the two stocks.


Get FitLife Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTLF vs. The Competition

MetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$100.88M$1.25B$4.94B$7.48B
Dividend YieldN/A4.51%2.87%3.87%
P/E Ratio25.764.48217.8615.69
Price / Sales3.5015.493,209.89201.58
Price / Cash22.49256.6294.4854.64
Price / Book4.772.314.464.68
Net Income$4.43M-$182.25M$112.73M$210.91M
7 Day Performance2.16%-1.17%4.91%2.78%
1 Month Performance3.00%-3.56%10.02%3.89%
1 Year Performance19.32%-11.67%12.58%8.07%

FitLife Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDXC
ChromaDex
4.0781 of 5 stars
$1.73
+4.8%
$5.80
+235.3%
+0.6%$129.96M$72.05M-19.22113Upcoming Earnings
News Coverage
High Trading Volume
MDWD
MediWound
1.4602 of 5 stars
$14.68
+4.9%
$32.00
+118.0%
+13.1%$135.20M$26.50M-8.3483Analyst Downgrade
BGXX
Bright Green
0 of 5 stars
$0.20
+5.2%
N/A-73.9%$37.18MN/A-3.3723Short Interest ↑
NAII
Natural Alternatives International
0 of 5 stars
$6.05
-0.3%
N/A-34.0%$36.84M$154.01M-8.64317Analyst Report
News Coverage
ACB
Aurora Cannabis
0.7421 of 5 stars
$3.31
+2.5%
N/A-61.5%$180.53M$174.88M-1.141,338Stock Split
Short Interest ↓
High Trading Volume
MNMD
Mind Medicine (MindMed)
1.5562 of 5 stars
$5.56
+11.6%
$23.50
+322.7%
+45.8%$222.96MN/A-2.9648Analyst Report
Analyst Revision
News Coverage
Gap Up
High Trading Volume
CGC
Canopy Growth
2.1889 of 5 stars
$3.53
+1.7%
$4.87
+37.9%
-85.4%$321.64M$362.24M-0.231,621Short Interest ↑
SYRE
Spyre Therapeutics
1.517 of 5 stars
$24.91
+3.8%
$33.50
+34.5%
N/A$100.86M$1.05M-0.3369Upcoming Earnings
Short Interest ↑
High Trading Volume
BTAI
BioXcel Therapeutics
4.1035 of 5 stars
$3.32
+7.1%
$21.13
+536.3%
-89.4%$100.87M$1.24M-0.45183Short Interest ↑
VAXX
Vaxxinity
2.3676 of 5 stars
$0.77
+8.4%
$7.00
+803.5%
-64.2%$98.21M$70,000.00-1.4987Positive News

Related Companies and Tools

This page (NASDAQ:FTLF) was last updated on 2/29/2024 by MarketBeat.com Staff